| 查看: 896 | 回复: 6 | |||||||||
| 当前只显示满足指定条件的回帖，点击这里查看本话题的所有回帖 | |||||||||
[交流]
【2014-10-31】Pulsus出版集团当代医学论坛 & 征稿（通知）
|
|||||||||
Call for Papers Current Oncology (www.current-oncology.com) Current Oncology is a peer-reviewed, Canadian based and internationally respected journal, indexed by Science Citation Index (SCI) with an Impact Factor (IF) of 1.473 (2013 Journal Citation Reports, Science Edition). Published bi-monthly, plus special supplemental issues, Current Oncology represents a multidisciplinary medium encompassing health care workers in the field of cancer therapy to report upon and to review progress in the management of this disease. The journal publishes a range of article types that encompass all aspects of cancer medicine: Original articles, Review articles, Commentaries, Practice guidelines, Letters to the Editor Perspectives, Short communications and Case reports. Manuscripts must be solely the work of the author(s) stated, must not have been previously published elsewhere, and must not be under consideration by another journal. Articles published in the journal contain information that is relevant directly to clinical oncology practice, and have clear potential for application to the current or future practice of cancer medicine. Current Oncology aims to facilitate the communication from the laboratory to the bedside; contributing to cancer prevention, treatment, early detection, diagnosis, survivorship and rehabilitation. All papers should be written to be clearly understandable to the journal’s readers in a wide range of specialties. Submissions in the area of basic research are not accepted by the journal. In 2012, the journal had over 250 submissions and an article acceptance rate of 57%. Articles submitted to the journal undergo our rigorous peer review process and must be accepted prior to publication. For further information about our peer review policy, please visit https://www.current-oncology.com ... issions#PeerReview. Benefits of Publishing with Current Oncology include: • Articles are freely and permanently accessible online immediately upon publication 相关信息访问中文网站 “朋博学者网”通知 https://www.medicinepub.com/inde ... tid=3&id=22 [ Last edited by Paulwolf on 2014-11-19 at 05:50 ] |
回复此楼» 猜你喜欢
有多少人是今天查系统知道结果的？
已经有19人回复
-
有没有仍没收到信息的
已经有7人回复
-
国社科又开始会评了，不知道这次命运如何
已经有4人回复
-
售SCI文章，我:8O5.5.1.O.54,科目齐全,可+急
已经有8人回复
-
售SCI文章，我:8O5.5.1.O.54,科目齐全,可+急
已经有7人回复
-
售SCI一区T0P文章，我:8O.55.1.O.54,科目全,可伽急
已经有8人回复
-
售SCI文章，我:8O.5.5.1O.54,科目全,可十急
已经有8人回复
-
售SCI一区T0P文章，我:8.O.55.1.O54,科目全,可伽急
已经有8人回复
-
售SCI一区文章，我:8.O.551.O.5.4,科目全,可伽急
已经有5人回复
-
找导师
已经有6人回复
» 抢金币啦！回帖就可以得到:
-
云南大学丁军桥团队2027年博士招生
+1/1986
-
散金币祈福
+5/368
-
货币银行学通俗教材版（一部超越哈耶克的经济学）
+1/253
-
【毕业前夕，畅谈科研】文集
+1/165
-
原子层沉积（ALD）磁控溅射PECVD等微纳代工服务：18817872921
+1/100
-
厦门大学崔明旭课题组招收2027届推免硕士/直博与申请考核博士生（金属有机、高分子）
+1/34
-
无穷无尽的科研生活焦虑
+4/20
-
招收CSC博士生（2027年9月入学）
+1/10
-
香港科技大学(广州) 强化学习、机器人、具身智能方向等方向硕博-27 spring fall
+1/9
-
南京航空航天大学激光焊接与再制造技术研究所招收2027年博士研究生
+1/8
-
厦大化院海优团队招收2027级【博士】和【推免硕士】研究生各2名
+1/6
-
2026年工程管理与智慧城市国际会议 (EMSC 2026)
+1/4
-
寻求合作【出版代理】兼职推广｜无需坐班｜一单5000元
+1/2
-
项目助理招聘启事
+1/2
-
（香港大学）智能制造实验室招收27年春秋季入学全奖博士和硕士研究生
+1/2
-
北航-国家级人才团队-招2027年9月博士
+1/2
-
专利审查意见答复，是AI辅助生成中很难的一个功能...
+1/2
-
中国科学院杭州医学研究所-科研助理，博士后及2027级博士招聘
+1/2
-
上海大学优青团队招聘硕士、博士研究生、博士后、实验员以及相关教职人员
+1/2
-
寻求合作【大学教师】兼职出版顾问｜无需坐班｜一单5000元
+1/1
7楼2014-10-20 15:22:51
简单回复
yuguiyan3楼
2014-10-19 21:27
回复
xmh880523(金币+1): 谢谢参与
， [ 发自小木虫客户端 ]
大内总管5楼
2014-10-19 21:33
回复
xmh880523(金币+1): 谢谢参与
